First Affiliated Hospital of Chongqing Medical University Reports Findings in Ga strointestinal Stromal Tumors (Advanced gastrointestinal stromal tumor: reliable classification of imatinib plasma trough concentration via machine learning)

扫码查看

Abstract

By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News – New research on Digestive System Disea ses and Conditions - Gastrointestinal Stromal Tumors is the subject of a report. According to news originating from Chongqing, People’s Republic of China, by Ne wsRx correspondents, research stated, “Patients with advanced gastrointestinal s tromal tumors (GISTs) exhibiting an imatinib plasma trough concentration (IM C) under 1100 ng/ml may show a reduced drug response rate, leading to the suggestio n of monitoring for IM C. Consequently, the objective of this research was to cr eate a customized IM C classification model for patients with advanced GISTs fro m China.”

Key words

Chongqing/People’s Republic of China/A sia/Antineoplastics/BCR-ABL Tyrosine Kinase Inhibitors/Blood/Cyborgs/Digest ive System Diseases and Conditions/Digestive System Neoplasms/Drugs and Therap ies/Emerging Technologies/Gastroenterology/Gastrointestinal Diseases and Cond itions/Gastrointestinal Neoplasms/Gastrointestinal Stromal Tumors/Health and Medicine/Hematology/Imatinib Therapy/Machine Learning/Pharmaceuticals/Plasm a/Protein Kinase Inhibitors/Tyrosine Kinase Inhibitors

引用本文复制引用

出版年

2024

Robotics & Machine Learning Daily News

ISSN：

段落导航